Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Classement en actions #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Prix de l'action
$2.04
Dernière synchronisation: 2025-12-09
Capitalisation boursière
$35.38M
Changement (1 jour)
0.00%
Changement (1 an)
-2.39%
Pays
IE
Échange Mural Oncology plc (MURA)

Catégorie

Historique du prix de l'action pour Mural Oncology plc (MURA)
Prix de clôture le plus élevé : $2.04 le 2025-12-01

Prix de clôture le plus bas : $3.85 le 2023-11-01
Historique du prix de l'action de Mural Oncology plc de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$760.05 6.79%
CH